<DOC>
	<DOCNO>NCT00367003</DOCNO>
	<brief_summary>The purpose propose study evaluate safety , feasibility efficacy chronic , high frequency stimulation subgenual cingulate white matter ( Cg25WM ) use ANS Totally Implantable Deep Brain Stimulation System adjunctive treatment severe treatment-refractory Major Depression twenty TRD patient , investigate potential mechanism action intervention .</brief_summary>
	<brief_title>Deep Brain Stimulation Treatment Resistant Depression</brief_title>
	<detailed_description>Major Depression one common costly psychiatric disorder . While depression effectively treat majority patient either medication form evidence-based psychotherapy , 20 % patient fail respond standard intervention . For patient , trial-and-error combination multiple medication electroconvulsive therapy often require ( Kennedy Lam 2003 ; UK ECT Review Group 2003 ) . For patient remain severely depressed despite aggressive approach , new strategy need . Specific Aim 1 . To ass safety tolerability acute chronic Cg25-DBS . Specific Aim 2 . To assess antidepressant efficacy active Cg25-DBS treatment-resistant depressed patient .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<criteria>Minimum Eligibility Criteria Age 1870 year old . Currently insured receive Medicare . Ability provide write informed consent . Diagnosis Major Depressive Episode Bipolar Type II current episode depress Current episode duration least 1 year Failure respond minimum four different antidepressant treatment . Failure intolerance adequate course electroconvulsive therapy ( ECT ) episode . All patient must establish outpatient psychiatrist willing sign write release allow study investigator give receive information psychiatrist Willing temporarily relocate Atlanta area least 34 month return require followup visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Depression , Unipolar , Bipolar-II , DBS , Imaging</keyword>
</DOC>